Tandem Diabetes Care, Inc. (TNDM)
NASDAQ: TNDM · Real-Time Price · USD
13.86
+0.33 (2.44%)
At close: May 19, 2026, 4:00 PM EDT
13.95
+0.09 (0.65%)
After-hours: May 19, 2026, 6:51 PM EDT
Tandem Diabetes Care Stock Forecast
Stock Price Forecast
According to 24 analysts polled by S&P Global, Tandem Diabetes Care stock has a consensus rating of "Buy" and an average price target of $30.52. The average 1-year stock price forecast is 120.20% higher than the current stock price, while the lowest is $20 (+44.30%) and the highest is $55 (+296.83%).
Price Target: $30.52 (+120.20%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Tandem Diabetes Care stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 3 | 4 | 4 | 4 |
| Buy | 4 | 4 | 4 | 5 | 5 | 5 |
| Hold | 10 | 11 | 12 | 9 | 10 | 11 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 16 | 17 | 19 | 18 | 19 | 20 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B of A Securities | B of A Securities | Hold Maintains $35 → $25 | Hold | Maintains | $35 → $25 | +80.38% | May 18, 2026 |
| Benchmark | Benchmark | Hold Initiates n/a | Hold | Initiates | n/a | n/a | May 12, 2026 |
| Truist Securities | Truist Securities | Strong Buy Reiterates $35 → $31 | Strong Buy | Reiterates | $35 → $31 | +123.67% | May 11, 2026 |
| Barclays | Barclays | Buy Maintains $56 → $55 | Buy | Maintains | $56 → $55 | +296.83% | May 11, 2026 |
| TD Cowen | TD Cowen | Strong Buy Maintains $25 → $28 | Strong Buy | Maintains | $25 → $28 | +102.02% | Apr 20, 2026 |
Financial Forecast
Revenue This Year
1.10B
from 1.01B
Increased by 7.91%
Revenue Next Year
1.23B
from 1.10B
Increased by 12.51%
EPS This Year
-0.68
from -3.04
EPS Next Year
0.07
from -0.68
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 1.1B | 1.3B | ||||||
| Avg | 1.1B | 1.2B | ||||||
| Low | 1.0B | 1.1B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 11.9% | 21.4% | ||||||
| Avg | 7.9% | 12.5% | ||||||
| Low | 2.9% | 4.3% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -0.43 | 0.61 | ||||||
| Avg | -0.68 | 0.07 | ||||||
| Low | -0.97 | -0.57 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.